This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
DeVita VT Jr : The consequences of the chemotherapy of Hodgkin disease; the 10th David A Karnofsky Memorial lecure. Cancer 47:_, 1981
Glodin A, Venditi JM, Humphreys SR, Mantel N: Quantitative evaluation of chemotherapeutic agents against advanced leukemia in mice. J Natl Cancer Inst 21 : 495, 1958
Skip er HE, Sehabel FM Jr, Wilcox WS: Experimental evaluation Of potential anticancer agents XIII. On the criteria and kinetics associated with ‘CurabIlity’ of experimental leukemia. Cancer Chemother Rep 35 : 3, 1964
Bruce WR, Meeker RE, Powers WE, Valeriote FA: Comparison of the dose and time survival Curves for normal hematopoietic and lymphoma colony forming cells exposed to vinblastine, vineristine arabinosyl cytosine and amethopterin. J Natl Cancer Inst 42 : 1015, 1969
DeVita VT Jr., Simon RM, Hubbard SM, et al: Curability of advanced Hodgkin’s disease with chemotherapy : Long term follow up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92 : 587, 1980
Bonadonna G, Zucali R, Manfardini S, Delena M, Uslcnghi C: Combination Chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36: 252 1975
Santoro A, Bonfante V, Bonadonna G: Salvage Chemotherapy with ABVD in MOPP resistant Hodgkin’s disease. Ann Intern Med 96: 139, 1982
Santoro A, Bonydonna G, Bonfante V, Valagussa P: Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N Engl J Med 306 : 770, 1982
Coltman CA Jr: Chemotherapy of advanced Hodgkin disease. Seminar Oncol 7:155, 1980
Goldie J H, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63 : 1727, 1979
Wiernik PH, Longo D, Duffey PL et al: MOPP vs MOPP alternating with streptozotocin, CCNU, adriamycin and bluomy- cin (SCAB) for advanced Hodgkin’s disease. Proc Am Assoc Cancer Res 22 : 159, 1981
About this article
Cite this article
Choudhry, V.P. Therapy for Advanced Hodgkin’s Disease. Indian J Pediatr 49, 823–825 (1982). https://doi.org/10.1007/BF02976976
- Neonatal Jaundice
- Monthly Cycle